Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Zynerba Pharmaceuticals, Inc. | Chief Financial Officer | Common Stock | 0 | $1.33 | Oct 10, 2023 | Direct | |
Zynerba Pharmaceuticals, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 0 | Oct 10, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ZYNE | Zynerba Pharmaceuticals, Inc. | Oct 10, 2023 | 4 | $0 | 4 | Oct 11, 2023 | Chief Financial Officer |
ZYNE | Zynerba Pharmaceuticals, Inc. | Sep 12, 2023 | 2 | -$11.9K | 4 | Sep 14, 2023 | Chief Financial Officer |
ZYNE | Zynerba Pharmaceuticals, Inc. | Feb 7, 2023 | 2 | -$3.9K | 4 | Feb 9, 2023 | Chief Financial Officer |
ZYNE | Zynerba Pharmaceuticals, Inc. | Jan 31, 2023 | 2 | -$3.53K | 4 | Feb 2, 2023 | Chief Financial Officer |
ZYNE | Zynerba Pharmaceuticals, Inc. | Jan 23, 2023 | 2 | -$10.6K | 4 | Jan 25, 2023 | Chief Financial Officer |
ZYNE | Zynerba Pharmaceuticals, Inc. | Jul 18, 2022 | 2 | -$6.61K | 4 | Jul 20, 2022 | Chief Financial Officer |
ZYNE | Zynerba Pharmaceuticals, Inc. | Jan 26, 2022 | 2 | $0 | 4 | Jan 28, 2022 | Chief Financial Officer |